Bioluminescence imaging enhances analysis of drug responses in a patient-derived xenograft model of pediatric ALL

PURPOSE: Robust preclinical models of pediatric acute lymphoblastic leukemia (ALL) are essential in prioritizing promising therapies for clinical assessment in high-risk patients. Patient-derived xenograft (PDX) models of ALL provide a clinically relevant platform for assessing novel drugs, with eff...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Jones, Luke, Richmond, Jennifer, Evans, Kathryn, Carol, Hernan, Jing, Duohui, Kurmasheva, Raushan T., Billups, Catherine A., Houghton, Peter J., Smith, Malcolm A., Lock, Richard B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943062/
https://ncbi.nlm.nih.gov/pubmed/28119366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-2392
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller